Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent

Radiology

Volumn 275, Issue 3, 2015, Pages 783-791

  Radbruch, Alexander ^a,b   Weberling, Lukas D ^a   Kieslich, Pascal J ^c   Eidel, Oliver ^a   Burth, Sina ^a   Kickingereder, Philipp ^a   Heiland, Sabine ^a   Wick, Wolfgang ^a   Schlemmer, Heinz Peter ^b   Bendszus, Martin ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF MANNHEIM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; BEVACIZUMAB; GADOLINIUM PENTETATE MEGLUMINE; GADOTERATE MEGLUMINE; CONTRAST MEDIUM; GADOLINIUM PENTETATE; MEGLUMINE; ORGANOMETALLIC COMPOUND;

ADULT; ARTICLE; BRAIN LYMPHOMA; BRAIN REGION; CANCER RADIOTHERAPY; CONTRAST ENHANCEMENT; DENTATE NUCLEUS; DRUG RETENTION; DRUG STRUCTURE; FEMALE; GLIOBLASTOMA; GLIOMA; GLOBUS PALLIDUS; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; SIGNAL PROCESSING; STUDENT T TEST; CEREBELLUM NUCLEUS; COMPARATIVE STUDY; METABOLISM; MIDDLE AGED;

CEREBELLAR NUCLEI; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; GLOBUS PALLIDUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEGLUMINE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; RETROSPECTIVE STUDIES;

EID: 84930863146     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2015150337     Document Type: Article

References (16)

1. Kanda T, Ishii K, Kawaguchi H, Kitajima K, Takenaka D. High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material. Radiology 2014;270(3):834-841.
2. Errante Y, Cirimele V, Mallio CA, Di Lazzaro V, Zobel BB, Quattrocchi CC. Progressive increase of T1 signal intensity of the dentate nucleus on unenhanced magnetic resonance images is associated with cumulative doses of intravenously administered gadodiamide in patients with normal renal function, suggesting dechelation. Invest Radiol 2014;49(10):685-690.
3. Kanda T, Osawa M, Oba H, et al. High signal intensity in dentate nucleus on unenhanced T1-weighted MR images: association with linear versus macrocyclic gadolinium chelate administration. Radiology 2015 Jan 27:140364. [Epub ahead of print]
4. Idée JM, Port M, Raynal I, Schaefer M, Le Greneur S, Corot C. Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: a review. Fundam Clin Pharmacol 2006;20(6):563-576.
5. Port M, Idée JM, Medina C, Robic C, Sabatou M, Corot C. Efficiency, thermodynamic and kinetic stability of marketed gadolinium chelates and their possible clinical consequences: a critical review. Biometals 2008;21(4):469-490.
6. Frenzel T, Lengsfeld P, Schirmer H, Hütter J, Weinmann HJ. Stability of gadolinium-based magnetic resonance imaging contrast agents in human serum at 37 degrees C. Invest Radiol 2008;43(12):817-828.
7. Gibby WA, Gibby KA, Gibby WA. Comparison of Gd DTPA-BMA (Omniscan) versus Gd HP-DO3A (ProHance) retention in human bone tissue by inductively coupled plasma atomic emission spectroscopy. Invest Radiol 2004;39(3):138-142.
8. Aronen HJ, Gazit IE, Louis DN, et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994;191(1):41-51.
9. Rouder JN, Speckman PL, Sun D, Morey RD, Iverson G. Bayesian t tests for accepting and rejecting the null hypothesis. Psychon Bull Rev 2009;16(2):225-237.
10. Wetzels R, Wagenmakers EJ. A default Bayesian hypothesis test for correlations and partial correlations. Psychon Bull Rev 2012;19(6):1057-1064.
11. White GW, Gibby WA, Tweedle MF. Comparison of Gd(DTPA-BMA) (Omniscan) versus Gd(HP-DO3A) (ProHance) relative to gadolinium retention in human bone tissue by inductively coupled plasma mass spectroscopy. Invest Radiol 2006;41(3):272-278.
12. Maeda T, Goto H, Hara H, et al. Comparison of Gd-DTPA-BMA versus Gd-DOTA of gadolinium retention in human bone tissue with normal renal function [abstr]. In: Radiological Society of North America Scientific Assembly and Annual Meeting Program. Oak Brook, Ill: Radiological Society of North America, 2014; 161.
13. Kasahara S, Miki Y, Kanagaki M, et al. Hyperintense dentate nucleus on unenhanced T1-weighted MR images is associated with a history of brain irradiation. Radiology 2011;258(1):222-228.
14. McDonald RJ, McDonald JS, Kallmes DF, et al. Intracranial gadolinium deposition after contrast-enhanced MR imaging. Radiology 2015 Mar 5:150025. [Epub ahead of print]
15. Hals PA, Hogset A. Deposition of gadolinium after high and low doses of gadolinium chloride to mice: organ distribution, elimination and subcellular localization in liver cells [abstr]. In: Book of abstracts: Society of Magnetic Resonance in Medicine 1990. Berkeley, Calif: Society of Magnetic Resonance in Medicine, 1990; 1199.
16. Wedeking P, Tweedle M. Comparison of the biodistribution of 153Gd-labeled Gd(DTPA)2-, Gd(DOTA)-, and Gd(acetate) n in mice. Int J Rad Appl Instrum B 1988;15(4):395-402.